'Pioneering' new scanner used for brain tumour patients trialled in world-first
Field cycling imaging (FCI) derives from MRI but can work at low and ultra-low magnetic fields, which means it is capable of seeing how organs are affected by diseases in ways that were previously not possible.
'Pioneering' new scanner used for brain tumour patients trialled in world-first
Field cycling imaging (FCI) derives from MRI but can work at low and ultra-low magnetic fields, which means it is capable of seeing how organs are affected by diseases in ways that were previously not possible.